ID24878A - Turunan ariltiazolidinedion - Google Patents

Turunan ariltiazolidinedion

Info

Publication number
ID24878A
ID24878A IDW20001163A ID20001163A ID24878A ID 24878 A ID24878 A ID 24878A ID W20001163 A IDW20001163 A ID W20001163A ID 20001163 A ID20001163 A ID 20001163A ID 24878 A ID24878 A ID 24878A
Authority
ID
Indonesia
Prior art keywords
ariltiazolidinedion
ppar
thiazolidinediones
hypertriglyceridemia
hyperglycemia
Prior art date
Application number
IDW20001163A
Other languages
English (en)
Inventor
Soumya P Sahoo
Richard L Tolman
Wei Han
Feffrey Bergmann
Conrad Santini
Vicki R Lombardo
Ranjit Desai
Julia K Boueres
Dominick F Gratale
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816279.5A external-priority patent/GB9816279D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ID24878A publication Critical patent/ID24878A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20001163A 1997-12-19 1998-12-18 Turunan ariltiazolidinedion ID24878A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6827197P 1997-12-19 1997-12-19
GBGB9816279.5A GB9816279D0 (en) 1998-07-27 1998-07-27 Arylthiazolidinedione derivatives
US10523898P 1998-10-22 1998-10-22

Publications (1)

Publication Number Publication Date
ID24878A true ID24878A (id) 2000-08-31

Family

ID=27269416

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001163A ID24878A (id) 1997-12-19 1998-12-18 Turunan ariltiazolidinedion

Country Status (21)

Country Link
EP (1) EP1040102B1 (id)
JP (1) JP3373198B2 (id)
KR (1) KR20010033355A (id)
CN (1) CN1282325A (id)
AT (1) ATE352545T1 (id)
AU (1) AU740733B2 (id)
BG (1) BG104602A (id)
BR (1) BR9813801A (id)
CA (1) CA2315397C (id)
DE (1) DE69836980T2 (id)
EA (1) EA200000687A1 (id)
ES (1) ES2281146T3 (id)
HU (1) HUP0101366A2 (id)
ID (1) ID24878A (id)
IL (1) IL136138A0 (id)
IS (1) IS5506A (id)
NO (1) NO20003112L (id)
PL (1) PL340958A1 (id)
SK (1) SK9212000A3 (id)
TR (1) TR200001753T2 (id)
WO (1) WO1999032465A1 (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824614D0 (en) 1998-11-11 1999-01-06 Glaxo Group Ltd Chemical compounds
DE60035639T2 (de) * 1999-05-20 2008-05-21 Ciba Specialty Chemicals Holding Inc. Hydroxydiphenyletherverbindungen
EP1194146B1 (en) * 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
AU5876900A (en) * 1999-06-18 2001-01-09 Merck & Co., Inc. Process for making arylthiazolidinedione derivatives
CA2382966A1 (en) 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
WO2001034200A1 (fr) * 1999-11-10 2001-05-17 Takeda Chemical Industries, Ltd Inhibiteurs de prise de poids
AU2001298065A1 (en) * 2001-01-12 2003-09-02 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
US20040077689A1 (en) * 2001-04-25 2004-04-22 Yasuo Sugiyama Abc expression promoters
WO2004011448A1 (en) * 2002-07-25 2004-02-05 Merck & Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
CA2507465C (en) * 2002-11-26 2009-04-28 Pfizer Products Inc. Phenyl substituted piperidine compounds for use as ppar activators
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
AU2004285849B2 (en) * 2003-09-19 2011-04-28 Janssen Pharmaceutica, N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
ES2555031T3 (es) 2003-09-19 2015-12-28 Janssen Pharmaceutica N.V. Ácidos y análogos 4-((fenoxialquilo)tio)-fenoxiacéticos
ATE363475T1 (de) * 2004-01-20 2007-06-15 Merck & Co Inc Antidiabetische oxazolidindione und thiazolidindione
WO2006138328A1 (en) * 2005-06-14 2006-12-28 Merck & Co., Inc. Process for the production of antidiabetic oxazolidinediones
EP1907381A4 (en) * 2005-07-06 2009-08-26 Merck & Co Inc OXAZOLIDINEDIONES AND ANTIDIABETIC THIAZOLIDINEDIONES
EP1909789A4 (en) * 2005-07-20 2009-10-21 Merck & Co Inc OXAZOLIDINEDIONES AND ANTIDIABETIC THIAZOLIDINEDIONES
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
ATE236137T1 (de) * 1996-02-02 2003-04-15 Merck & Co Inc Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
WO1997028115A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Antidiabetic agents
EP0904079B1 (en) * 1996-02-02 2004-03-24 Merck & Co., Inc. Antidiabetic agents
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO20003112L (no) 2000-08-18
BR9813801A (pt) 2000-10-03
KR20010033355A (ko) 2001-04-25
PL340958A1 (en) 2001-03-12
AU740733B2 (en) 2001-11-15
AU1833499A (en) 1999-07-12
EP1040102B1 (en) 2007-01-24
WO1999032465A1 (en) 1999-07-01
EP1040102A4 (en) 2002-11-27
EA200000687A1 (ru) 2000-12-25
CA2315397C (en) 2007-08-07
DE69836980D1 (de) 2007-03-15
HUP0101366A2 (hu) 2001-09-28
JP3373198B2 (ja) 2003-02-04
CN1282325A (zh) 2001-01-31
TR200001753T2 (tr) 2000-11-21
IL136138A0 (en) 2001-05-20
JP2001526278A (ja) 2001-12-18
IS5506A (is) 2000-05-23
ES2281146T3 (es) 2007-09-16
NO20003112D0 (no) 2000-06-16
BG104602A (bg) 2001-01-31
SK9212000A3 (en) 2001-02-12
EP1040102A1 (en) 2000-10-04
ATE352545T1 (de) 2007-02-15
DE69836980T2 (de) 2007-11-15
CA2315397A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
ID24878A (id) Turunan ariltiazolidinedion
DE60029446D1 (de) Arylthiazolidinedione und aryloxa zolidinedion-derivate
AU7705601A (en) N-substituted indoles useful in the treatment of diabetes
WO2002026729A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO2002064094A3 (en) 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
WO2002060434A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
NO20015607D0 (no) Glukagonantagonister/inversagonister
WO2002060388A3 (en) Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
DE69433501D1 (de) Oxazole zur behandlung von zytokinvermittelten erkrankungen
DE69625926D1 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
DE69620306D1 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
DE69008010D1 (de) Sauerstoffdelignifizierung und enzymatische Behandlung.
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
IS5194A (is) Notkun þíasólídíndíonafleiða við meðferð á fjölblöðrueggjastokkaheilkennum og þungunarsykursýki
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
NO905291L (no) Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer.
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996264D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
ECSP993022A (es) Derivados de ariltiazolidindiona
DE69526731D1 (en) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
AR018898A1 (es) Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento
DK0458892T3 (da) Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration
MY139550A (en) Indoles having anti-diabetic activity
NO911011D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.
NO910704D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.